↓ Skip to main content

Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

Overview of attention for article published in BMC Cancer, February 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Published in
BMC Cancer, February 2015
DOI 10.1186/s12885-015-1052-0
Pubmed ID
Authors

Margarita García, Mercedes Martinez-Villacampa, Cristina Santos, Valentin Navarro, Alex Teule, Ferran Losa, Aleydis Pisa, Maria Cambray, Gemma Soler, Laura Lema, Esther Kreisler, Agnes Figueras, Xavier San Juan, Francesc Viñals, Sebastiano Biondo, Ramon Salazar

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 22%
Other 4 9%
Researcher 4 9%
Student > Bachelor 4 9%
Student > Doctoral Student 4 9%
Other 12 26%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 27 59%
Biochemistry, Genetics and Molecular Biology 3 7%
Agricultural and Biological Sciences 1 2%
Nursing and Health Professions 1 2%
Psychology 1 2%
Other 3 7%
Unknown 10 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2017.
All research outputs
#7,950,636
of 9,171,443 outputs
Outputs from BMC Cancer
#3,017
of 3,774 outputs
Outputs of similar age
#214,666
of 253,834 outputs
Outputs of similar age from BMC Cancer
#55
of 72 outputs
Altmetric has tracked 9,171,443 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,774 research outputs from this source. They receive a mean Attention Score of 3.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,834 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.